Results 61 to 70 of about 32,822 (166)

Aspirin Desensitization and Percutaneous Coronary Intervention in a Patient with Aspirin Hypersensitivity and Acute Coronary Syndrome: A Case Report

Journal of Nepal Medical Association
Hypersensitivity to aspirin is rare disorder occurring in 1.88% of the patients. Aspirin-hypersensitive patients requiring single antiplatelet agent may be treated with clopidogrel, an alternative antiplatelet agent.
Suman Acharya, Siddinath Gyawali , Sanjeev Kharel, Dinesh Upreti, Khem Raj Bhusal, Silvia Maharjan, Hemanta Shrestha, Ratna Mani Gajurel   +7 more
doaj   +1 more source

Recurrent Stroke Prevention Strategies in Patients Receiving Acute Stroke Reperfusion Therapies (CoPrime Study Survey)

Cerebrovascular Diseases Extra
Introduction: Patients who have undergone reperfusion treatments, like all ischemic stroke patients, are at risk of recurrent ischemic strokes in the first 90 days.
Rezan Ashayeri Ahmadabad, Mohammed Almekhlafi, PN Sylaja, Aviraj Deshmukh, Jesse Dawson, Aleksandra Pikula, Muhammad Shazam Hussain, Yiran Zhang, Negar Asdaghi, Sung-II Sohn, Mohammad Wasay, Ashfaq Shuaib, Brian Buck, Mahesh Pundlik Kate   +13 more
doaj   +1 more source

Dynamics of hemostasis system parameters in assessing the risk of complications in the patients with acute myocardial infarction receiving antiplatelet therapy

Трансплантология (Москва)
Background. Current treatment of patients with myocardial infarction is based on the strategy of early invasive coronary intervention in combination with dual antiplatelet therapy - with acetylsalicylic acid and a P2Y12 blocker of platelet adenosine ...
T. R. Gvindzhiliya, I. M. Kuzmina, E. V. Klychnikova, E. V. Tazina, A. A. Kochetova, N. A. Muradyan, A. S. Bogdanova   +6 more
doaj   +1 more source

Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel

Vascular Health and Risk Management, 2009
Zuzana Motovska, Petr WidimskyThird Medical Faculty of Charles University and University Hospital Kralovske Vinohrady, Prague, Czech RepublicAbstract: Dual oral antiplatelet therapy, aspirin plus thienopyridine, has permitted a rapid increase in the use ...
Zuzana Motovska, Petr Widimsky
doaj  

Management of Bleeding Disorder During Dual Antiplatelet Therapy. [PDF]

JACC Case Rep
Madaudo C, Galassi AR, Vadalà G.
europepmc   +1 more source

Is Aspirin Still Indispensable After PCI-Rethinking Dual Antiplatelet Therapy in Contemporary Practice. [PDF]

J Cardiovasc Dev Dis
Yadav K, Ahmed SES, Abdelgader M, Khalid R, Veerasamy M, Das A, Bulluck H.   +6 more
europepmc   +1 more source

Reply: Analysis of Dual Antiplatelet Therapy.

Journal of the American College of Cardiology, 2016
Yeh, Robert W., Kereiakes, Dean J., Mauri, Laura   +2 more
openaire   +2 more sources

Indications for Dual Antiplatelet Therapy in Coil-Only Treatment of Ruptured Intracranial Aneurysms: A Narrative Review. [PDF]

Med Sci Monit
Sowa M, Sowa J.
europepmc   +1 more source

Dual antiplatelet therapy in acute ischemic stroke: Does diabetes mellitus define a target population? [PDF]

Neurotherapeutics
Nedelcu S.
europepmc   +1 more source

Indobufen Dual Antiplatelet Therapy (DAPT) Versus Aspirin Dual Antiplatelet Therapy (DAPT) After Percutaneous Coronary Intervention (PCI): A Systematic Review and Meta-Analysis. [PDF]

Catheter Cardiovasc Interv
Saeed O, Saeed A, Barakat O, Bawjeh A, Saka T, Yousif TM, Adim AM, Elhadi M, Mamas MA.   +8 more
europepmc   +1 more source